Himaging Technology key facts
as of Oct 2026- Developer of diagnostic imaging equipment intended for clinical visualization and procedural guidance.
- Himaging Technology is valued at approximately $10.8M as of Oct 2026 (last reported valuation).
- It has raised $2.2M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Suzhou Mingcheng Venture, Bison Capital Financial Holdings, Mihe Investment, Origins Capital, TigerYeah Capital.
- Status: Privately Held (backing).
Himaging Technology's last reported valuation, Jan 2020. Nothing priced has surfaced since.
- ·Watch Himaging Technology: the Monday email on marks, rounds and moves
Himaging Technology funding rounds
No funding rounds for Himaging Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Himaging Technology
5Himaging Technology valuation
Himaging Technology's last reported valuation was $10.8 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.
Himaging Technology investors
5 investors are on record for Himaging Technology, including Suzhou Mingcheng Venture, Bison Capital Financial Holdings, Mihe Investment and Origins Capital.
About Himaging Technology
Developer of diagnostic imaging equipment intended for clinical visualization and procedural guidance. The company offers single-use endoscopic devices with enhanced image processing, multi-scale texture structure enhancement, hemoglobin visualization, and electronic chromo features, serving healthcare providers in urology, respiratory, and otolaryngology fields to reduce cross-contamination risks, improve diagnostic accuracy, and streamline operational efficiency through cost-effective, high-performance imaging tools.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2016
- Website
- himaging.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.